What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?

Antoine Pariente¹, Joëlle Micallef², Amir Lahouegue³, Mathieu Molimard⁴, Marine Auffret⁵, Laurent Chouchana⁶, Bernard Denis⁷, Jean Luc Faillie⁸, Aurelie Grandvuillemin⁹, Louis Letinier¹⁰, Evelyne Pierron¹¹, Catherine Pons¹², Iris Pujade¹⁰, Heather Rubino¹³, Francesco Salvo⁴

¹Univ. Bordeaux, Inserm, BPH, U1219, Equipe AHeaD, 33000 Bordeaux, France; CHU de Bordeaux, service de Pharmacologie Médicale, 33000 Bordeaux, France. Electronic address: antoine.pariente@u-bordeaux.fr.

²AMU INS Inserm 1106, centre régional de pharmacovigilance, pharmacologie clinique, APHM, 13005 Marseille, France.

³Pharmacovigilance et information médicale, AstraZeneca, 92400 Courbevoie, France.

⁴Univ. Bordeaux, Inserm, BPH, U1219, Equipe AHeaD, 33000 Bordeaux, France; CHU de Bordeaux, service de Pharmacologie Médicale, 33000 Bordeaux, France.

⁵Service hospitalo-universitaire de pharmacotoxicologie, centre régional de pharmacovigilance, hospices civils de Lyon, UMR CNRS 5558, université de Lyon 1, 69000 Lyon, France.

⁶Service de pharmacologie, centre-université Paris Cité, centre régional de pharmacovigilance, hôpital Cochin, AP-HP, 75014 Paris, France.

⁷Formation recherche, union francophone patients partenaire, 75012 Paris, France.

⁸Inserm, département de pharmacologie médicale et toxicologie, centre régional de pharmacovigilance, institut Desbrest d'épidémiologie et de santé publique, CHU de Montpellier, université Montpellier, 34090 Montpellier, France.

⁹Centre régional de pharmacovigilance de Bourgogne, CHU de Dijon, 21000 Dijon, France.

¹⁰Synapse Medicine, 33000 Bordeaux, France.

¹¹Agence nationale de sécurité du médicament et des produits de santé (ANSM), 93285 Saint-Denis, France.

¹²Roche, 92100 Boulogne, France.

¹³Pfizer, Inc, 235, East 42nd Street, NYC, NY, 10007 New York, USA.

PubMed DOI

Abstract

In 2018, the "Ateliers de Giens" (Giens Workshops) devoted a workshop to artificial intelligence (AI) and led its experts to confirm the potential contribution and theoretical benefit of AI in clinical research, pharmacovigilance, and in improving the efficiency of care. The 2022 workshop is a continuation of this reflection on AI and intelligent automation (IA) by focusing on its contribution to…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.